Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Bioparticle is not a typical horizontal SaaS product, but a specialized analytics platform and service provider for life sciences and nanoparticle research. Its website highlights Pangnostics digital flow cytometry, the ZetaView series of multi-parameter NTA instruments, and characterization applications for extracellular vesicles, viruses/VLPs, lipid nanoparticles, nanobubbles, and environmental nanoparticles. In addition, through its partnership with Unplex, Bioparticle offers MedTech quality and regulatory services, Odoo ERP digital transformation, engineering development, and scientific consulting.
The platform focuses on high-sensitivity particle analysis: measuring particle size, concentration, Zeta potential, and fluorescence, with an emphasis on single-molecule-level detection, direct digital counting, calibration-free concentration measurement, and adaptive scanning. For research targets such as EVs, LNPs, and VLPs, these capabilities help identify hidden subpopulations, assess stability and integrity, and support process optimization. On the services side, it covers ISO 13485, FDA 21 CFR Part 820, MDR, cGMP readiness, technical documentation, regulatory submissions, as well as customized Odoo ERP implementation and integration with R&D, QA/RA, and supply chain workflows.
The captured text does not disclose any packages, quotes, subscription models, trials, or free versions. Given that it involves scientific instruments, specialized antibodies/calibrators, and consulting services, actual procurement will most likely require requesting a quote, although this is not explicitly stated in the website copy.
The strengths are its clear technical positioning and relatively comprehensive capabilities around nanoparticle analysis, from detection and characterization to consulting. Its emphasis on high sensitivity, reproducibility, and regulatory readiness also fits well with biopharmaceutical R&D scenarios. The downside is limited disclosure from an enterprise software perspective: it does not specify cloud or on-premise deployment, user permissions, APIs, developer support, platform security certifications, or after-sales SLAs. While Odoo-related capabilities are mentioned, the specific module boundaries and implementation methodology are not very transparent.
It is better suited to research institutions, biotech companies, biopharmaceutical teams, CROs/CDMOs working on EVs, LNPs, viruses/VLPs, nanobubbles, and related areas, as well as MedTech/Biotech companies that need quality systems, regulatory submissions, engineering development, or Odoo ERP implementation. It is not ideal for teams looking for a general-purpose enterprise SaaS tool.
The text does not provide information about access from mainland China, service delivery, local agents, or compliance support. The current assessment is unknown.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on bioparticle.com official site.
bioparticle.com is an Unknown Health provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach bioparticle.com directly.